Scientists in Australia have made an exciting discovery that could help people living with type 1 diabetes. In a recent study, they found a way to “reboot” certain cells in the pancreas so they start producing insulin again. And the surprising part? They used a cancer drug to do it.
Imagine living with constant, unpredictable seizures that medications just can't control. That’s the reality for many people with epilepsy. But a new kind of treatment using stem cells might be about to change lives.
In a small but exciting trial in the U.S., two epilepsy patients received a one-time brain injection of specially grown brain cells. The results? Their seizures dropped dramatically — by over 90% — and the effects lasted for a whole year.
In 2017, British filmmaker and adventure photographer Paddy Scott thought his intense stomach pain was nothing serious. He was only 34, in great shape, and living an active life. But after a hospital visit and a routine colonoscopy, he got news that changed everything: he had advanced bowel cancer that had already spread to his liver.
Stories like Paddy’s are no longer rare.
What happens when artificial intelligence becomes a Twitch streamer? Meet Neuro-sama, a virtual anime girl who chats with fans, plays Minecraft, sings karaoke, and even discusses cuttlefish camouflage. She’s not human—but she’s quickly becoming a favorite on the platform.
Neuro-sama is the creation of a developer known online as Vedal, who built her using AI technology similar to ChatGPT, combined with a text-to-speech program and a character model made in the Unity game engine. The result? A digital personality that interacts in real time with thousands of fans.
A recent survey has revealed that many top business leaders are deeply concerned about the future of artificial intelligence (AI)—with a shocking number even saying it could pose a threat to humanity itself.
According to results shared with CNN, 42% of CEOs surveyed at the Yale CEO Summit believe AI could destroy humanity within five to ten years.
A new study out of UC San Francisco has found that a widely available allergy medication may do more than just stop sniffles—it might actually help repair nerve damage caused by multiple sclerosis (MS).
Researchers discovered that clemastine, an over-the-counter antihistamine, helped restore the protective myelin sheath that covers nerve fibers—something that’s severely damaged in people with MS. This breakthrough could offer a new way to treat the disease, focusing on actual nerve repair rather than just managing the immune system’s attack.
The World Economic Forum (WEF) has released a bold new proposal calling for a massive reduction in the number of cars on the road around the world. Their target? Cutting global car ownership by 75% by the year 2050.
That would mean dropping the number of personal vehicles from around 1.45 billion today to just 500 million in the next few decades.
Next time you’re stuck waiting in line at the grocery store, take a look around. Chances are, you’ll be surrounded by candy bars, soda, and salty chips. That’s no accident.
A new study from UC Davis found that about 70% of the food and drinks sold at checkout lanes are unhealthy. When it comes to small, snack-sized items, the number jumps to 89%.
Junk Food Takes Center Stage
Researchers looked at checkout lanes in 102 stores across four California cities: Davis, Sacramento, Oakland, and Berkeley. They found the top items near the register were:
For over 50 years, the chemical industry kept a dangerous secret: that a group of chemicals known as PFAS—used in products like nonstick pans, waterproof clothing, and food packaging—were harming people and the planet. These toxic substances are now found almost everywhere, and a new study shows just how much companies like DuPont and 3M knew—and covered up.
The billionaire Sackler family, who owned Purdue Pharma, will no longer face civil lawsuits over their role in the U.S. opioid crisis. In exchange, they’ve agreed to pay $6 billion as part of a settlement aimed at supporting addiction treatment and recovery efforts across the country.
Purdue Pharma, the maker of OxyContin, filed for bankruptcy in 2019 after being hit with thousands of lawsuits. The company was widely accused of helping fuel the opioid epidemic by aggressively marketing its painkiller as safe and non-addictive—claims that were later proven false.